|
|
格雷戈里吉尔伯特
第一队格雷戈里吉尔伯特
Merrill Lynch.
第二队
大卫斯坦伯格德意志
第三队
理查德银雷曼
赛跑者
科里戴维斯，Natixis Bleichroeder.;亚伦（Ronny）Gal，桑福德伯恩斯坦;Marc Goodman，瑞士信贷;安德鲁斯旺森，花旗
格雷戈里吉尔伯特是第一次，拥有一个客户呼唤“对股票移动的好感”。Gilbert, 34, who earned a bachelor’s degree with an emphasis on premedical studies from Pennsylvania State University in 1996 and joined Merrill Lynch in 1998, uses his premed education to draw information from physicians and drugmakers for trading-oriented picks like an in-and-out call on Adams Respiratory Therapeutics. Gilbert recommended the Chester, New Jersey–based company’s stock in March, calling it undervalued. In June, with the stock up 20.9 percent, he told investors to take profits. By mid-September shares had fallen 14.7 percent. Newcomer David Steinberg of Deutsche Bank Securities was “early and right” on Shire, says one client. Steinberg, a fan of the U.K. company’s efforts to rebuild its pipeline since 1999, made it the centerpiece of his coverage for the past two years. For the 12 months ended mid-September, the stock was up 43.9 percent. Returning in third, Lehman Brothers’ Richard Silver has “the best sense of the generics cycle,” notes one investor. In June 2006 he highlighted Teva Pharmaceutical Industries, an Israeli off-patent drugmaker. By mid-September 2007 the stock was up 23.6 percent.